Try our beta test site

ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by ViiV Healthcare
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
ViiV Healthcare
ClinicalTrials.gov Identifier:
NCT02075593
First received: February 27, 2014
Last updated: February 24, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2021
  Estimated Primary Completion Date: October 2021 (Final data collection date for primary outcome measure)